Biomerica, Inc. (BMRA)

Biomerica Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Revenue	4.46	5.31	5.42	5.34	18.87	7.2
Revenue Growth (YoY)	-20.05%	-1.92%	1.42%	-71.71%	162.13%	7.56%
Cost of Revenue	4.21	4.81	4.8	4.89	15.89	6.83
Gross Profit	0.25	0.5	0.61	0.45	2.98	0.37
Selling, General & Admin	4.64	4.61	5.49	6.09	5.7	5.67
Research & Development	0.87	1.02	1.49	1.58	1.81	2.19
Total Operating Expenses	5.52	5.64	6.98	7.67	7.51	7.87
Operating Income	-5.27	-5.14	-6.37	-7.22	-4.53	-7.5
Interest Income	1.25	0.17	0.43	0.13	0.03	0.07
Interest Expense	-	-	-	-	-	-0
Other Non-Operating Income (Expense)	-	-	-	0	-	-
Total Non-Operating Income (Expense)	1.25	0.17	0.43	0.13	0.03	0.07
Pretax Income	-4.02	-4.97	-5.94	-7.09	-4.51	-7.43
Provision for Income Taxes	-0.01	-0	-0.04	-0.05	-0.02	-0.01
Net Income	-4.03	-4.97	-5.98	-7.14	-4.53	-7.45
Net Income to Common	-4.03	-4.97	-5.98	-7.14	-4.53	-7.45
Shares Outstanding (Basic)	3	2	2	2	2	1
Shares Outstanding (Diluted)	3	2	2	2	2	1
Shares Change (YoY)	39.54%	9.22%	18.87%	11.69%	6.24%	17.34%
EPS (Basic)	-1.37	-2.16	-2.84	-4.00	-2.88	-4.96
EPS (Diluted)	-1.37	-2.16	-2.84	-4.00	-2.88	-4.96
Free Cash Flow	-2.97	-3.84	-5.41	-5.54	-0.54	-5.39
Free Cash Flow Per Share	-	-1.67	-2.57	-3.13	-0.34	-3.61
Gross Margin	5.61%	9.38%	11.28%	8.35%	15.78%	5.09%
Operating Margin	-118.10%	-96.72%	-117.58%	-135.29%	-24.03%	-104.18%
Profit Margin	-89.88%	-93.60%	-108.85%	-131.82%	-23.76%	-103.07%
FCF Margin	-66.51%	-72.32%	-99.94%	-103.73%	-2.84%	-74.84%
EBITDA	-4.86	-4.74	-5.99	-6.87	-3.94	-7.12
EBITDA Margin	-108.95%	-89.19%	-110.67%	-128.71%	-20.87%	-98.96%
EBIT	-5.27	-5.14	-6.37	-7.22	-4.53	-7.5
EBIT Margin	-118.10%	-96.72%	-117.58%	-135.29%	-24.03%	-104.18%
Effective Tax Rate	0.22%	0.02%	0.71%	0.72%	0.53%	0.18%

Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q